Therapeutic Aids Inc Asheville, NC - 28801

Therapeutic Aids Inc is categorized under Hospital Equipment Repair and Refinishing in Asheville, NC and active since 1972.

Therapeutic Aids Inc was established in 1972, and today employs 1 to 4, earning Unknown per year. This is a Hospital Equipment Repair and Refinishing business, which does work in the B2C market, and is classified as a Hospital Equipment Repair and Refinishing, under code number 9211200 by the NAICS.

If you are seeking more information, feel free to contact Dr Robert A Resnick at the company’s single location by writing to 338 Merrimon Avenue, Asheville, North Carolina NC 28801 or by phoning (828) 255-0025. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Therapeutic Aids Inc
Contact Person: Dr Robert A Resnick
Address: 338 Merrimon Avenue, Asheville, North Carolina 28801
Phone Number: (828) 255-0025
Annual Revenue (USD): Unknown
Founded: 1972
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hospital Equipment Repair and Refinishing
SIC Code: 7699
NAICS Code: 9211200
Share This Business:

Therapeutic Aids Inc was started in 1972 to provide professional Hospital Equipment Repair and Refinishing under the SIC code 7699 and NAICS code 9211200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Dr Robert A Resnick for inquiries that concern Therapeutic Aids Inc by calling the company number (828) 255-0025, as your correspondence is most welcome. Additionally, the physical location of the single location of Therapeutic Aids Inc can be found at the coordinates 35.61029,-82.55478 as well as the street address 338 Merrimon Avenue in Asheville, North Carolina 28801.

For its online presence, you may visit Therapeutic Aids Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.